Microsoft greatly increased the finance capacities of its Copilot AI, announcing the addition of 25 new finance skills and partner-built plugins across the platform for audit, tax, compliance, bookkeeping and more.
Collective raised $100 million in funding, including a $40 million Series B led by General Catalyst, QED, and Gradient Ventures, along with Intuit Ventures, FT Partners, and SemperVirens, plus $60 million from General Catalyst’s Customer Value Fund.
US firms with clients that sell into, own subsidiaries in or buy from suppliers in Europe will be asked about the e-invoicing mandate, often by clients who think the rules apply when they do not, or the other way around.
After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead asset.
On its third-quarter earnings investor call Thursday morning, Merck executives touted recent pipeline wins alongside a strong performance for subcutaneous Keytruda and pulmonary arterial hypertension drug Winrevair that drove the pharma’s overall sales expectations to surpass expectations.
In addition to canning an Orum-acquired blood cancer candidate last month, Bristol Myers Squibb cut a Prothena-partnered neuro asset in the third quarter. But with sales climbing 7%, the Big Pharma raised its full-year revenue forecast.